Follow
Rosella Silvestrini
Rosella Silvestrini
Meldola, Milano, Forlė
Verified email at istitutotumori.mi.it
Title
Cited by
Cited by
Year
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more
G Bonadonna, U Veronesi, C Brambilla, L Ferrari, A Luini, M Greco, ...
JNCI: Journal of the National Cancer Institute 82 (19), 1539-1545, 1990
8341990
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
R Silvestrini, S Veneroni, MG Daidone, E Benini, P Boracchi, M Mezzetti, ...
JNCI: Journal of the National Cancer Institute 86 (7), 499-504, 1994
6161994
‘Daunomycin’, a new antibiotic of the rhodomycin group
A Di Marco, M Gaetani, P Orezzi, BM Scarpinato, R Silvestrini, M Soldati, ...
Nature 201 (4920), 706-707, 1964
3581964
p53 as an independent prognostic marker in lymph node-negative breast cancer patients
R Silvestrini, E Benini, MG Daidone, S Veneroni, P Boracchi, V Cappelletti, ...
JNCI: Journal of the National Cancer Institute 85 (12), 965-970, 1993
3251993
Cell kinetics as a prognostic marker in node‐negative breast cancer
R Silvestrini, MG Daidone, G Gasparini
Cancer 56 (8), 1982-1987, 1985
2381985
Cell proliferation and its relationship to clinical features and relapse in breast cancers
C Gentili, O Sanfilippo, R Silvestrini
Cancer 48 (4), 974-979, 1981
1981981
Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity
A Di Marco, F Zunino, R Silvestrini, C Gambarucci, RA Gambetta
Biochemical Pharmacology 20 (6), 1323-1328, 1971
1861971
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.
R Silvestrini, E Benini, S Veneroni, MG Daidone, G Tomasic, ...
Journal of clinical oncology 14 (5), 1604-1610, 1996
1751996
Labeling index as a prognostic marker in non-Hodgkin's lymphomas
A Costa, G Bonadonna, E Villa, P Valagussa, R Silvestrini
Journal of the National Cancer Institute 66 (1), 1-5, 1981
1701981
Relationship between proliferative activity and estrogen receptors in breast cancer
R Silvestrini, MG Daidone, GD Fronzo
Cancer 44 (2), 665-670, 1979
1561979
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer
R Silvestrini, MG Daidone, G Di Fronzo, A Morabito, P Valagussa, ...
Breast cancer research and treatment 7, 161-169, 1986
1541986
Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.
R Silvestrini, MG Daidone, A Luisi, P Boracchi, M Mezzetti, G Di Fronzo, ...
Journal of clinical oncology 13 (3), 697-704, 1995
1351995
Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer
G Bonadonna, P Valagussa, G Tancini, A Rossi, C Brambilla, M Zambetti, ...
NCI Monogr 1, 45-49, 1986
1281986
Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers
MG Daidone, R Silvestrini, A D'Errico, GD Fronzo, E Benini, AM Mancini, ...
International journal of cancer 48 (4), 529-532, 1991
1241991
Inhibiting effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells
A Di Marco, R Silvestrini, S Di Marco, T Dasdia
The Journal of cell biology 27 (3), 545-550, 1965
1231965
Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine
O Sanfilippo, E Ronchi, C De Marco, G Di Fronzo, R Silvestrini
European Journal of Cancer and Clinical Oncology 27 (2), 155-158, 1991
1211991
Expression of p53, glutathione S-transferase-π, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer
R Silvestrini, S Veneroni, E Benini, MG Daidone, A Luisi, M Leutner, ...
Journal of the National Cancer Institute 89 (9), 639-645, 1997
1201997
Cell kinetics as a prognostic indicator in node-negative breast cancer
R Silvestrini, MG Daidone, P Valagussa, G Di Fronzo, G Mezzanotte, ...
European Journal of Cancer and Clinical Oncology 25 (8), 1165-1171, 1989
1201989
Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.
MG Daidone, A Luisi, S Veneroni, E Benini, R Silvestrini
Endocrine-related cancer 6 (1), 61-68, 1999
1171999
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data
V Casadio, D Calistri, M Tebaldi, S Bravaccini, R Gunelli, G Martorana, ...
Urologic oncology: seminars and original investigations 31 (8), 1744-1750, 2013
1012013
The system can't perform the operation now. Try again later.
Articles 1–20